Key Points
- On January 7 CEO Grigorios Siokas purchased 124,880 shares at $0.52 each, bringing his total ownership to 6,975,604 shares (a 1.82% increase) valued at about $3.63 million.
- Siokas has been steadily accumulating shares—roughly 816,720 shares bought across multiple trades since November 19, representing about $445,000 of purchases in total.
- Cosmos Health is a small-cap company (~$19.4M) with negative EPS and margins and a consensus analyst rating of Sell, while institutional investors (e.g., Citadel) have recently increased stakes.
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 124,880 shares of Cosmos Health stock in a transaction that occurred on Wednesday, January 7th. The shares were bought at an average price of $0.52 per share, with a total value of $64,937.60. Following the transaction, the chief executive officer owned 6,975,604 shares of the company's stock, valued at $3,627,314.08. This trade represents a 1.82% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Grigorios Siokas also recently made the following trade(s):
- On Tuesday, January 6th, Grigorios Siokas acquired 133,953 shares of Cosmos Health stock. The stock was bought at an average cost of $0.54 per share, for a total transaction of $72,334.62.
- On Friday, December 19th, Grigorios Siokas purchased 88,314 shares of Cosmos Health stock. The shares were purchased at an average price of $0.49 per share, with a total value of $43,273.86.
- On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.42 per share, for a total transaction of $70,758.24.
- On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The stock was bought at an average price of $0.64 per share, with a total value of $48,870.40.
- On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The stock was purchased at an average price of $0.63 per share, for a total transaction of $35,111.16.
- On Friday, November 21st, Grigorios Siokas acquired 56,080 shares of Cosmos Health stock. The stock was acquired at an average price of $0.68 per share, for a total transaction of $38,134.40.
- On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The stock was bought at an average cost of $0.62 per share, for a total transaction of $31,815.30.
- On Wednesday, November 19th, Grigorios Siokas acquired 61,614 shares of Cosmos Health stock. The shares were bought at an average cost of $0.65 per share, with a total value of $40,049.10.
Cosmos Health Stock Performance
Shares of NASDAQ COSM opened at $0.52 on Friday. The stock has a market cap of $19.41 million, a price-to-earnings ratio of -0.69 and a beta of 5.37. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. Cosmos Health Inc. has a 1-year low of $0.28 and a 1-year high of $1.32. The stock's 50-day moving average is $0.58 and its 200 day moving average is $0.73.
Cosmos Health (NASDAQ:COSM - Get Free Report) last posted its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%.The business had revenue of $17.11 million during the quarter, compared to the consensus estimate of $16.40 million. On average, sell-side analysts anticipate that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC boosted its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 133.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 225,507 shares of the company's stock after acquiring an additional 128,776 shares during the period. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 at the end of the most recent reporting period. Institutional investors own 12.61% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the company. Wall Street Zen raised Cosmos Health to a "hold" rating in a research note on Saturday, September 20th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Cosmos Health in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of "Sell".
Read Our Latest Research Report on COSM
Cosmos Health Company Profile
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
